Who to call at Circle Pharma, and when
Fundz watches for the moments Circle Pharma starts buying, and tells you who to reach.
- An alert the day Circle Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Circle Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Circle Pharma. With Fundz connected, it knows.
LaunchCircle Pharma Launches Phase 1 Clinical Trial of CID-078, an Innovative Oral Cyclin A/B RxL Inhibitor for Advanced Solid Tumors.
South San FranciscoHealthcareHealth CareProduct Description
Circle Pharma, Inc. has announced the dosing of the first patient cohort in their Phase 1 clinical trial of CID-078, an oral cyclin A/B RxL inhibitor aimed at advanced solid tumors. The trial will explore the drug's effectiveness in patients with various types of cancer, including small cell lung cancer and certain types of breast cancer.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Circle Pharma ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Product Launch Insights
What this usually meansCircle Pharma shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.